Literature DB >> 9691890

The clinical radiobiology of brachytherapy.

R G Dale1, B Jones.   

Abstract

The unique geometrical features of brachytherapy, together with the wide variety of temporal patterns of dose delivery, result in important interactions between physics and radiobiology. These interactions exert a major influence on the way in which brachytherapy treatments should be evaluated, both in absolute and comparative terms. This article reviews the main physical and radiobiological aspects of brachytherapy and considers examples of their influence on specific types of treatment. The issues relating to the optimization of high dose rate brachytherapy are presented, together with the implications of multiphasic repair kinetics for low dose-rate and pulsed high dose rate brachytherapy. The opportunities for application of radiobiological principles to improve various brachytherapy techniques, together with the integration of brachytherapy with teletherapy, are also outlined. Equations for the numerical evaluation of brachytherapy treatments are presented in the Appendices.

Mesh:

Year:  1998        PMID: 9691890     DOI: 10.1259/bjr.71.845.9691890

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  27 in total

Review 1.  21 years of biologically effective dose.

Authors:  J F Fowler
Journal:  Br J Radiol       Date:  2010-07       Impact factor: 3.039

2.  AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.

Authors:  Ravinder Nath; William S Bice; Wayne M Butler; Zhe Chen; Ali S Meigooni; Vrinda Narayana; Mark J Rivard; Yan Yu
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

3.  Improved tumour response prediction with equivalent uniform dose in pre-clinical study using direct intratumoural infusion of liposome-encapsulated ¹⁸⁶Re radionuclides.

Authors:  Brian A Hrycushko; Steve Ware; Shihong Li; Ande Bao
Journal:  Phys Med Biol       Date:  2011-08-12       Impact factor: 3.609

4.  Investigating the dosimetric and tumor control consequences of prostate seed loss and migration.

Authors:  Courtney Knaup; Panayiotis Mavroidis; Carlos Esquivel; Sotirios Stathakis; Gregory Swanson; Dimos Baltas; Nikos Papanikolaou
Journal:  Med Phys       Date:  2012-06       Impact factor: 4.071

5.  Brachytherapy in the treatment of recurrent aggressive falcine meningiomas.

Authors:  Hussam Abou Al-Shaar; Kaith K Almefty; Mohammad Abolfotoh; Nils D Arvold; Phillip M Devlin; David A Reardon; Jay S Loeffler; Ossama Al-Mefty
Journal:  J Neurooncol       Date:  2015-08-08       Impact factor: 4.130

6.  Modelling the influence of treatment time on the biological effectiveness of single radiosurgery treatments: derivation of "protective" dose modification factors.

Authors:  Bleddyn Jones; John W Hopewell
Journal:  Br J Radiol       Date:  2018-08-21       Impact factor: 3.039

7.  Radiobiological equivalent of low/high dose rate brachytherapy and evaluation of tumor and normal responses to the dose.

Authors:  S Manimaran
Journal:  Radiat Med       Date:  2007-06-27

8.  An NTCP Analysis of Urethral Complications from Low Doserate Mono- and Bi-Radionuclide Brachytherapy.

Authors:  V E Nuttens; A E Nahum; S Lucas
Journal:  Prostate Cancer       Date:  2011-07-06

9.  Dose gradient impact on equivalent dose at 2 Gy for high dose rate interstitial brachytherapy.

Authors:  Jean-Michel Hannoun-Levi; Marie-Eve Chand-Fouche; Catherine Dejean; Adel Courdi
Journal:  J Contemp Brachytherapy       Date:  2012-03-30

10.  Pulsed dose rate brachytherapy of lip cancer.

Authors:  Krystyna Serkies; Adam Ziemlewski; Tomasz Sawicki; Joanna Kamińska; Rafał Dziadziuszko
Journal:  J Contemp Brachytherapy       Date:  2013-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.